The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A pilot study of tumor-derived exosomes as diagnostic and prognostic markers in breast cancer patients receiving neoadjuvant chemotherapy.
R. E. Raab
No relevant relationships to disclose
T. L. Pawlowski
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
D. Spetzler
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
M. R. Klass
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
C. D. Kuslich
Employment or Leadership Position - Caris Life Sciences
Stock Ownership - Caris Life Sciences
L. S. Bellin
No relevant relationships to disclose
J. H. Wong
No relevant relationships to disclose
A. S. Asch
No relevant relationships to disclose